Drug Database
Back to search

Switzerland· 56175001

Opatanol, Augentropfen

A olopatadine product, registered in Switzerland by Novartis Pharma Schweiz AG and dispensed under Swissmedic category B. The same ATC class is registered in 13 of our 19 countries.

Cat B (Swissmedic)ATC S01GX09

Checked against the register on

Informational only — not a medical device.

SOURCE REGISTER · CHPublic registernormalisedOpatanol, AugentropfenATCS01GX09REGISTER NO.56175001PACKS LISTED0CHECKEDJune 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about OpatanolAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Olopatadine is registered in 13 of 19 countries.

Countries holding a registration under ATC S01GX09 (olopatadine), each read from that country’s own register.

  • This record: Switzerland
  • 8 of them publish a price we can compare per daily dose
Search olopatadine products by name

Olopatadine · ATC S01GX09

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Manufacturer
Novartis Pharma Schweiz AG
Country
Switzerland (CH)
ATC code
S01GX09
ATC class
Olopatadine
Swissmedic category
B
Reimbursed
No
Last checked
June 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

142 interactions on record for olopatadine.

Graded by severity as the source publishes them — 142 info. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check olopatadine against other medicinesHow interaction checks work

Olopatadine · interactions on record

142 records

  • 142 info

Most severe, free to view

    Mechanism and what to do, in the interaction check
    Interaction register. Grades as the source publishes them.

    Same class

    Other records under S01GX09

    Olopatadine, as other registers publish it.

    All olopatadine products

    Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

    For developers

    The same record over the API, and the raw payload
    GET /v1/drugs/cda875aa-738a-43d6-8d0d-e3a4b904cd2d
GET /v1/drugs/cda875aa-738a-43d6-8d0d-e3a4b904cd2d?format=fhir

    Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

    {
  "source": "swissmedic_auth",
  "heilmittelcode": "Synthetika"
}
    API referenceMCP serverPlans

    See everything about olopatadine.

    This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

    Try it freeOpen in the console